Steidl, E., Pilatus, U., Hattingen, E., Steinbach, J. P., Zanella, F., Ronellenfitsch, M. W., & Bähr, O. (2016). Myoinositol as a Biomarker in Recurrent Glioblastoma Treated with Bevacizumab: A (1)H-Magnetic Resonance Spectroscopy Study. PLoS One.
Citação norma ChicagoSteidl, Eike, Ulrich Pilatus, Elke Hattingen, Joachim P. Steinbach, Friedhelm Zanella, Michael W. Ronellenfitsch, and Oliver Bähr. "Myoinositol As a Biomarker in Recurrent Glioblastoma Treated With Bevacizumab: A (1)H-Magnetic Resonance Spectroscopy Study." PLoS One 2016.
ציטוט MLASteidl, Eike, et al. "Myoinositol As a Biomarker in Recurrent Glioblastoma Treated With Bevacizumab: A (1)H-Magnetic Resonance Spectroscopy Study." PLoS One 2016.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.